相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。What Is Driving the Epidemiology of Methicillin-Resistant Staphylococcus aureus Infections in Europe?
Michael A. Borg et al.
MICROBIAL DRUG RESISTANCE (2021)
Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care ?
Tanner M. Johnson et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia
Erlinda R. Ulloa et al.
CLINICAL INFECTIOUS DISEASES (2020)
Ceftobiprole versus daptomycin in Staphylococcus aureus bacteremia: a novel protocol for a double-blind, Phase III trial
Kamal Hamed et al.
FUTURE MICROBIOLOGY (2020)
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia A Randomized Clinical Trial
Steven Y. C. Tong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
Erin K. McCreary et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
In MRSA bacteremia, adding a β-lactam to usual care did not improve a composite outcome at 90 days
Eleftheria Atalla et al.
ANNALS OF INTERNAL MEDICINE (2020)
Bacteremia due to Methicillin-Resistant Staphylococcus aureus An Update on New Therapeutic Approaches
Marisa Holubar et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2020)
Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis
Sara Alosaimy et al.
INFECTIOUS DISEASES AND THERAPY (2020)
Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
Matthew Geriak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
High-dose trimethoprim-sulfamethoxazole and clindamycin for Staphylococcus aureus endocarditis
Herve Tissot-Dupont et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
lAntibiotic Resistance and the MRSA Problem
Martin Vestergaard et al.
MICROBIOLOGY SPECTRUM (2019)
Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial
J. M. Pericas et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Methicillin-resistant Staphylococcus aureus
Andie S. Lee et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case-control study
Noa Eliakim-Raz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study
Samia Arshad et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment
Ali Hassoun et al.
CRITICAL CARE (2017)
Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial
Joshua S. Davis et al.
CLINICAL INFECTIOUS DISEASES (2016)
Comparative Fitness and Determinants for the Characteristic Drug Resistance of ST239-MRSA-III-t030 and ST239-MRSA-III-t037 Strains Isolated in China
Weilong Shang et al.
MICROBIAL DRUG RESISTANCE (2016)
Mechanisms of Methicillin Resistance in Staphylococcus aureus
Sharon J. Peacock et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 84 (2015)
Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009-13)
Helio S. Sader et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond
Natasha E. Holmes et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial
Mical Paul et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial
Mical Paul et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Ceftaroline fosamil salvage therapy: an option for reduced-vancomycin-susceptible MRSA bacteraemia
Bjoern A. Espedido et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
β-Lactams Enhance Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus Bacteremia Compared to Vancomycin Alone
Thomas J. Dilworth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Conceptual and Technical Challenges in Network Meta-analysis
Andrea Cipriani et al.
ANNALS OF INTERNAL MEDICINE (2013)
Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the seesaw effect: Taking advantage of the back door left open?
Jessica K. Ortwine et al.
DRUG RESISTANCE UPDATES (2013)
Treatment of Methicillin-Resistant Staphylococcus aureus Infections with a Minimal Inhibitory Concentration of 2 μg/mL to Vancomycin: Old (Trimethoprim/Sulfamethoxazole) versus New (Daptomycin or Linezolid) Agents
Michelle L. Campbell et al.
ANNALS OF PHARMACOTHERAPY (2012)
In Vitro Pharmacodynamics of Vancomycin and Cefazolin Alone and in Combination against Methicillin-Resistant Staphylococcus aureus
Mao Hagihara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The pharmacokinetic and pharmacodynamic properties of vancomycin
MJ Rybak
CLINICAL INFECTIOUS DISEASES (2006)
Experimental study on the efficacy of combinations of glycopeptides and β-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides
A Domenech et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
分享论文
